These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
62. Glomus tumors in individuals with neurofibromatosis type 1. Kumar MG; Emnett RJ; Bayliss SJ; Gutmann DH J Am Acad Dermatol; 2014 Jul; 71(1):44-8. PubMed ID: 24685357 [TBL] [Abstract][Full Text] [Related]
63. [Vitreo-retinal complications of hemoglobinopathy SC]. Ndiaye PA; Ndoye PA; Seye C; Wane A; De Medeiros M; Kameny A; Ba EA; Ndiaye MR; Wade A Dakar Med; 1998; 43(1):21-4. PubMed ID: 9827149 [TBL] [Abstract][Full Text] [Related]
64. Acquired tumors arising from congenital hypertrophy of the retinal pigment epithelium. Shields JA; Shields CL; Singh AD Arch Ophthalmol; 2000 May; 118(5):637-41. PubMed ID: 10815155 [TBL] [Abstract][Full Text] [Related]
65. Massive subretinal and vitreous haemorrhages at presentation in idiopathic thrombocytopenic purpura: report of a case and review of literature. Goel N; Arora S; Jain P; Ghosh B Clin Exp Optom; 2014 May; 97(3):270-3. PubMed ID: 23763572 [TBL] [Abstract][Full Text] [Related]
66. Ocular neovascularization in a patient with Fanconi anemia. Yahia SB; Touffahi SA; Zeghidi H; Zaouali S; Khairallah M Can J Ophthalmol; 2006 Dec; 41(6):778-9. PubMed ID: 17224966 [TBL] [Abstract][Full Text] [Related]
71. Aggressive retinal astrocytomas in four patients with tuberous sclerosis complex. Shields JA; Eagle RC; Shields CL; Marr BP Trans Am Ophthalmol Soc; 2004; 102():139-47; discussion 147-8. PubMed ID: 15747752 [TBL] [Abstract][Full Text] [Related]
72. Laser and ranibuzumab combination for retinal vasoproliferative tumor's management. Fernández-Martínez C; Martínez-Toldos JJ; Hernández-Artola F Arch Soc Esp Oftalmol; 2015 Dec; 90(12):593-6. PubMed ID: 26347320 [TBL] [Abstract][Full Text] [Related]
73. Juvenile xanthogranuloma and nevus anemicus in the diagnosis of neurofibromatosis type 1. Ferrari F; Masurel A; Olivier-Faivre L; Vabres P JAMA Dermatol; 2014 Jan; 150(1):42-6. PubMed ID: 24258576 [TBL] [Abstract][Full Text] [Related]
75. Lesions simulating retinoblastoma (pseudoretinoblastoma) in 604 cases: results based on age at presentation. Shields CL; Schoenberg E; Kocher K; Shukla SY; Kaliki S; Shields JA Ophthalmology; 2013 Feb; 120(2):311-6. PubMed ID: 23107579 [TBL] [Abstract][Full Text] [Related]
76. Comparative Study on the Efficacy and Safety of Tumor Resection in Vitrectomy for Retinal Vasoproliferative Tumors. Zheng B; Chen Y; Chen L; Chen H; Zheng J; Chen F; Song Z; Fu L; Hu X; Pan J; Lian H; Shen L; Li Q J Ophthalmol; 2019; 2019():7464123. PubMed ID: 30719338 [TBL] [Abstract][Full Text] [Related]
77. Long-term visual outcomes in patients with orbitotemporal neurofibromatosis. Greenwell TH; Anderson PJ; Madge SK; Selva D; David DJ Clin Exp Ophthalmol; 2014 Apr; 42(3):266-70. PubMed ID: 23926960 [TBL] [Abstract][Full Text] [Related]
78. Ophthalmological manifestations in VHL and NF 1: pathological and diagnostic implications. Kreusel KM Fam Cancer; 2005; 4(1):43-7. PubMed ID: 15883709 [TBL] [Abstract][Full Text] [Related]
79. Advances in treatment of retinal angiomas. Palmer JD; Gragoudas ES Int Ophthalmol Clin; 1997; 37(4):159-70. PubMed ID: 9429939 [TBL] [Abstract][Full Text] [Related]
80. Case Report: Pediatric Ocular Ischemia and Neovascular Glaucoma in Neurofibromatosis Type 1. Selvan H; Surve A; Sharma S; Venkatesh P; Sihota R Optom Vis Sci; 2022 May; 99(5):479-484. PubMed ID: 35121720 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]